Smoking and diabetes interplay: A comprehensive review and joint statement

Elsevier

Available online 29 June 2022, 101370

Diabetes & MetabolismAbstract

Evidence shows that smoking increases the risk of pre-diabetes and diabetes in the general population. Among persons with diabetes, smoking has been found to increase the risk of all-cause mortality and aggravate chronic diabetic complications and glycemic control. The current paper, which is a joint position statement by the French-Speaking Society on Tobacco (Société Francophone de Tabacologie) and the French-Speaking Society of Diabetes (Société Francophone du Diabète), summarizes the data available on the association between smoking and diabetes and on the impact of smoking and smoking cessation among individuals with type 1, type 2, and gestational diabetes mellitus. It also provides evidence-based information about the pharmacological and behavioral strategies for smoking cessation in these patients.

Keywords

Complications

Diabetes

Pre-diabetes

Smoking

Smoking cessation

AbbreviationsADVANCE

Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation

CHD

coronary heart disease

ESRD

end-stage renal disease

GDM

gestational diabetes mellitus

HOMA-β

homeostasis model assessment of β-cell function

IRS-1

insulin-receptor substrate-1

MI

motivational interviewing

NRT

nicotine replacement therapy

PAD

peripheral arterial disease

RCT

randomized controlled trial

T1DM

type 1 diabetes mellitus

T2DM

type 2 diabetes mellitus

VLDL

very-low-density lipoprotein

View full text

© 2022 Elsevier Masson SAS. All rights reserved.

留言 (0)

沒有登入
gif